Menta Capital’s Can-Fite BioPharma American Depositary Shares CANF Stock Holding History
Bought
Maintained
Sold
Other funds holding CANF
TAM
SM
PVH
Menta Capital's CANF Position: Q1 2017 in Review
Menta Capital sold out of Can-Fite BioPharma American Depositary Shares (CANF) in Q1 2017, closing a stake of 14 shares — an estimated $100K sold.
Menta Capital first reported a position in CANF in Q1 2015 and held it in 8 quarters. The position peaked at $116K in Q2 2016. 3 funds tracked by Wall St. Rank hold CANF as of Q1 2017.
- Menta Capital reported no remaining Can-Fite BioPharma American Depositary Shares position as of Q1 2017 after selling out during the quarter.
- Menta Capital sold 14 Can-Fite BioPharma American Depositary Shares shares in Q1 2017, an estimated $100K.
- Menta Capital first reported a position in Can-Fite BioPharma American Depositary Shares in Q1 2015 and held it in 8 quarters.
- Menta Capital's Can-Fite BioPharma American Depositary Shares position peaked at $116K in Q2 2016.
- 3 funds tracked by Wall St. Rank held Can-Fite BioPharma American Depositary Shares as of Q1 2017.
Based on Menta Capital's 13F filing for Q1 2017, filed 12 May 2017.